N-acetylcysteine rescues intracellular Ca2+ signalling and nitric oxide production in human aortic valve endothelial cells from patients with calcific aortic valve stenosis
Calcific aortic valve stenosis (CAVS), the most common valvular heart disease, is generally regarded as a progressive disease continuum evolving from aortic valve sclerosis (AVSc) to overt aortic stenosis (AS), characterized by increasing leaflet calcification and outflow obstruction. Endothelial dysfunction of the aortic valve plays a crucial role in the pathogenic mechanism leading to CAVS. A remarkable increase in oxidative stress contributes to endothelial injury in CAVS, thereby promoting endothelial-to-mesenchymal transition and impairing endothelium-dependent vasomotion and endothelial barrier function. Endothelial dysfunction can be accompanied by remodelling of the Ca 2+ handling machinery and restoring intracellular Ca 2+ signalling could represent a promising therapeutic strategy to recover endothelial function, including nitric oxide (NO) release. We adopted a multidisciplinary approach (i.e., RNA-seq analysis of Ca²⁺ toolkit-associated genes and single-cell Fura-2 Ca 2+ imaging for intracellular measurements) to investigate for the first time whether the Ca 2+ signalling toolkit is altered in human aortic valve endothelial cells (hVECs) from patients with CAVS (AS-hVECs) compared to VECs from control patients (hVECs; i.e., isolated from patients without stenosis). Bioinformatic analysis revealed that the transcripts encoding inositol-1,4,5-trisphosphate (InsP 3 ) receptors (InsP 3 Rs), i.e., ITPR1 , ITPR2 , and ITPR3 , which mediate Ca 2+ release from the endoplasmic reticulum (ER), were not altered, while the transcript encoding the ER Ca 2+ sensor STIM1, which initiates store-operated Ca 2+ entry (SOCE), was up-regulated in AS-hVECs. Capillary Western blot revealed that InsP 3 R and STIM1, but not Orai1 (the main pore-forming subunit of SOCE), proteins were significantly over-expressed in AS-hVECs. Unexpectedly, single-cell Fura-2 Ca 2+ imaging revealed that SOCE, a major driver of endothelial NO release, was remarkably down-regulated in AS-hVECs. Conversely, despite a reduction in the amount of releasable free ER Ca 2+ , physiological Ca 2+ release through InsP 3 Rs was unaffected, reflecting InsP 3 R hyper-responsiveness in AS-hVECs. However, N-acetyl-L-cysteine (NAC), a widely employed ROS scavenger, and the thiol-reducing agent dithiothreitol (DTT) fully rescued SOCE, consistent with the ROS-dependent inhibition of SOCE activation. Furthermore, pre-treatment with NAC also restored acetylcholine-induced NO release. These findings reveal that oxidative stress impairs SOCE in AS-hVECs and identify NAC as a potential therapeutic strategy to prevent endothelial dysfunction in this heart valve disease.
Authors
- Valentina Brunetti
- Francesco Domenico Moccia (ORCID: https://orcid.org/0000-0003-0010-0098)
- Ilaria Massaiu (ORCID: https://orcid.org/0000-0001-5805-1909)
- Sharon Negri (ORCID: https://orcid.org/0000-0003-4016-3384)
- Pawan Sirwan Faris (ORCID: https://orcid.org/0000-0001-6867-0359)
- Veronika A. Myasoedova (ORCID: https://orcid.org/0000-0001-8414-5300)
- Vincenza Valerio (ORCID: https://orcid.org/0000-0002-6344-267X)
- Paolo Poggio (ORCID: https://orcid.org/0000-0002-7225-3379)
- Giorgia Scarpellino (ORCID: https://orcid.org/0000-0003-1673-6146)
Institutions
- University of Molise (IT)
- University of Milan (IT)
- University of Pavia (IT)
- Centro Cardiologico Monzino (IT)
- OU Health (US)
- University of Oklahoma Health Sciences Center (US)
- Tishk International University (IQ)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-11-15
- DOI
- https://doi.org/10.1186/s12967-026-09166-y
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00